+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Forecast 2024-2030- Product Image
Global Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Forecast 2024-2030- Product Image
Sale

Global Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5665984
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biologics Contract Development Market size was estimated at USD 6.54 billion in 2023, USD 7.30 billion in 2024, and is expected to grow at a CAGR of 11.79% to reach USD 14.28 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biologics Contract Development Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biologics Contract Development Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biologics Contract Development Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Abzena Ltd., Aenova Holding GmbH, AGC Biologics GmbH, Avid Bioservices, Inc., Binex Co. Limited, Boehringer Ingelheim International GmbH, Cambrex Corporation, Catalent, Inc., Emergent BioSolutions, Inc., Fujifilm Holdings Corporation, Icon PLC, JRS PHARMA GmbH & Co. KG, JSR Life Sciences, LLC, Lonza Group AG, Parexel International Corporation, ProBioGen AG, Recipharm AB, Rentschler Biopharma SE, Samsung Biologics, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Inc., Toyobo Co., Ltd., and WuXi Biologics Inc.

Market Segmentation & Coverage

This research report categorizes the Biologics Contract Development Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source
    • Mammalian
    • Microbial
  • Type
    • Molecular Therapy
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
  • Disease Indication
    • Cardiovascular Disorders
    • Hematological Disorders
    • Immunological Disorders
    • Oncology
  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Preclinical
  • Service Type
    • Cell Line Development
      • Mammalian
      • Microbial
    • Process Development
      • Downstream
        • Impurity, Isolation, & Identification
        • Pharmaceutical Analysis
        • Physicochemical Characterization
      • Upstream
        • Mammalian
        • Microbial
  • End-User
    • Biopharmaceutical Companies
    • Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Biologics Contract Development Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biologics Contract Development Market?
  3. What are the technology trends and regulatory frameworks in the Biologics Contract Development Market?
  4. What is the market share of the leading vendors in the Biologics Contract Development Market?
  5. Which modes and strategic moves are suitable for entering the Biologics Contract Development Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biologics Contract Development Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for vaccine and biosimilar production
5.1.1.2. Government initiatives encouraging biologics activities
5.1.1.3. Improved operational efficiency and cost saving with biologics CDO
5.1.2. Restraints
5.1.2.1. Communication issues between end-user and CDO
5.1.3. Opportunities
5.1.3.1. Technological advancements in biologics development systems
5.1.3.2. Investments in new biologics contract development services expansion
5.1.4. Challenges
5.1.4.1. Concerns associated with breach of intellectual property
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Biologics Contract Development Market, by Source
6.1. Introduction
6.2. Mammalian
6.3. Microbial
7. Biologics Contract Development Market, by Type
7.1. Introduction
7.2. Molecular Therapy
7.3. Monoclonal Antibodies
7.4. Recombinant Proteins
7.5. Vaccines
8. Biologics Contract Development Market, by Disease Indication
8.1. Introduction
8.2. Cardiovascular Disorders
8.3. Hematological Disorders
8.4. Immunological Disorders
8.5. Oncology
9. Biologics Contract Development Market, by Phase
9.1. Introduction
9.2. Phase I
9.3. Phase II
9.4. Phase III
9.5. Preclinical
10. Biologics Contract Development Market, by Service Type
10.1. Introduction
10.2. Cell Line Development
10.3.1. Mammalian
10.3.2. Microbial
10.3. Process Development
10.4.1. Downstream
10.4.2.1. Impurity, Isolation, & Identification
10.4.2.2. Pharmaceutical Analysis
10.4.2.3. Physicochemical Characterization
10.4.2. Upstream
10.4.3.1. Mammalian
10.4.3.2. Microbial
11. Biologics Contract Development Market, by End-User
11.1. Introduction
11.2. Biopharmaceutical Companies
11.3. Research Laboratories
12. Americas Biologics Contract Development Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Biologics Contract Development Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Biologics Contract Development Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
16. Competitive Portfolio
16.1. Key Company Profiles
16.1.1. AbbVie, Inc.
16.1.2. Abzena Ltd.
16.1.3. Aenova Holding GmbH
16.1.4. AGC Biologics GmbH
16.1.5. Avid Bioservices, Inc.
16.1.6. Binex Co. Limited
16.1.7. Boehringer Ingelheim International GmbH
16.1.8. Cambrex Corporation
16.1.9. Catalent, Inc.
16.1.10. Emergent BioSolutions, Inc.
16.1.11. Fujifilm Holdings Corporation
16.1.12. Icon PLC
16.1.13. JRS PHARMA GmbH & Co. KG
16.1.14. JSR Life Sciences, LLC
16.1.15. Lonza Group AG
16.1.16. Parexel International Corporation
16.1.17. ProBioGen AG
16.1.18. Recipharm AB
16.1.19. Rentschler Biopharma SE
16.1.20. Samsung Biologics
16.1.21. Takeda Pharmaceutical Company Limited
16.1.22. Thermo Fisher Scientific, Inc.
16.1.23. Toyobo Co., Ltd.
16.1.24. WuXi Biologics Inc.
16.2. Key Product Portfolio
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. BIOLOGICS CONTRACT DEVELOPMENT MARKET RESEARCH PROCESS
FIGURE 2. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOLOGICS CONTRACT DEVELOPMENT MARKET DYNAMICS
FIGURE 7. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 8. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 12. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 14. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 16. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 18. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 22. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. BIOLOGICS CONTRACT DEVELOPMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 28. BIOLOGICS CONTRACT DEVELOPMENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BIOLOGICS CONTRACT DEVELOPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 6. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 9. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULAR THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 14. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 19. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 24. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 26. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 30. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 32. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY IMPURITY, ISOLATION, & IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHARMACEUTICAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHYSICOCHEMICAL CHARACTERIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 37. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 74. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 124. AUSTRALIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 126. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 128. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 129. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 130. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 131. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 132. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 133. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 134. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 136. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 138. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 139. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 141. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 142. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 143. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 144. INDIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 154. INDONESIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 156. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 158. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 159. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 160. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 161. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 162. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 163. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 164. JAPAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 174. MALAYSIA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 184. PHILIPPINES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 194. SINGAPORE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 204. SOUTH KOREA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 214. TAIWAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 216. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 218. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 219. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 220. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 221. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 222. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 223. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 224. THAILAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 234. VIETNAM BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 246. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 247. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 257. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 259. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 260. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 261. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 262. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 263. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 264. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 265. EGYPT BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 267. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 269. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 270. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 271. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 272. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 273. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 274. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 275. FINLAND BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 276. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 277. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 279. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 280. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 281. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 282. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 283. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 284. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 285. FRANCE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 287. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 288. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 289. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 290. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 291. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 292. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 293. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 294. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 295. GERMANY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 305. ISRAEL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 307. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 308. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 309. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 310. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 311. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 312. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 313. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM, 2018-2030 (USD MILLION)
TABLE 314. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM, 2018-2030 (USD MILLION)
TABLE 315. ITALY BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

  • AbbVie, Inc.
  • Abzena Ltd.
  • Aenova Holding GmbH
  • AGC Biologics GmbH
  • Avid Bioservices, Inc.
  • Binex Co. Limited
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Emergent BioSolutions, Inc.
  • Fujifilm Holdings Corporation
  • Icon PLC
  • JRS PHARMA GmbH & Co. KG
  • JSR Life Sciences, LLC
  • Lonza Group AG
  • Parexel International Corporation
  • ProBioGen AG
  • Recipharm AB
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.
  • Toyobo Co., Ltd.
  • WuXi Biologics Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.28 Billion
Compound Annual Growth Rate11.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Biologics Contract Development Market Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication (Oncology, Immunological Disorders), By Region And Segment Forecasts, 2023-2030 - Product Image

Biologics Contract Development Market Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication (Oncology, Immunological Disorders), By Region And Segment Forecasts, 2023-2030

  • Report
  • 150 Pages
  • Global
From
Global Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Forecast 2024-2030 - Product Image

Global Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Global Biologics Contract Manufacturing Market by Product (Biosimilar, Insulin, Interferons), Platform (Mammalian, Microbial), Therapeutic Area, Scale of Operation - Forecast 2024-2030 - Product Image

Global Biologics Contract Manufacturing Market by Product (Biosimilar, Insulin, Interferons), Platform (Mammalian, Microbial), Therapeutic Area, Scale of Operation - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • 799 Pages
  • Global
From
Biologics Contract Development Global Market Report 2024 - Product Image

Biologics Contract Development Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.